8/5/11 11:08 | 8/4/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Goddard Colin | MD | D | | P | 49 | 16.17 | 33 | 3 | 57 | 8 | D | 4 | -43 | -39 | -44 | -39 | -33 | -27 | -21 | 2 | -1 | -23 | -36 | -34 | |
3/23/11 15:08 | 3/22/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Goddard Colin | MD | D | | P | 75 | 27.41 | 33 | 3 | New | 3 | D | 999 | -16 | -9 | 13 | 8 | 7 | -3 | 0 | -1 | -1 | 7 | -6 | -52 | |
3/3/10 19:10 | 3/1/10 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 1,535 | 23.25 | 0 | 66 | 72 | 158 | D | | | | | | | | | | | | | | |
3/3/10 19:10 | 3/1/10 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -3,641 | 55.17 | 0 | -66 | -29 | 158 | D | | | | | | | | | | | | | | |
6/6/07 13:21 | 6/4/07 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 282 | 6.88 | 0 | 41 | 88 | 88 | D | | | | | | | | | | | | | | |
6/6/07 13:21 | 6/4/07 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -1,516 | 36.98 | 0 | -41 | -32 | 88 | D | | | | | | | | | | | | | | |
8/29/06 17:43 | 8/25/06 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S | -100 | 36.32 | 0 | -3 | -4 | 75 | D | | | | | | | | | | | | | | |
8/29/06 17:41 | 8/25/06 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 236 | 7.88 | 0 | 30 | 62 | 78 | D | | | | | | | | | | | | | | |
8/29/06 17:41 | 8/25/06 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -982 | 36.05 | 0 | -27 | -26 | 78 | D | | | | | | | | | | | | | | |
6/6/06 19:53 | 6/2/06 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 216 | 9.00 | 0 | 24 | 69 | 59 | | | | | | | | | | | | | | | |
6/6/06 19:53 | 6/2/06 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -723 | 30.13 | 0 | -24 | -29 | 59 | | | | | | | | | | | | | | | |
10/24/05 19:11 | 10/20/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 180 | 9.00 | 0 | 20 | 52 | 59 | D | | | | | | | | | | | | | | |
4/19/05 16:41 | 4/15/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 36 | 9.00 | 0 | 4 | 12 | 39 | D | | | | | | | | | | | | | | |
4/19/05 16:41 | 4/15/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -200 | 50.00 | 0 | -4 | -9 | 39 | D | | | | | | | | | | | | | | |
3/3/05 16:18 | 3/1/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 36 | 9.00 | 0 | 4 | 12 | 39 | D | | | | | | | | | | | | | | |
3/3/05 16:18 | 3/1/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -216 | 53.98 | 0 | -4 | -9 | 39 | D | | | | | | | | | | | | | | |
2/3/05 15:19 | 2/1/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 36 | 9.00 | 0 | 4 | 12 | 39 | D | | | | | | | | | | | | | | |
2/3/05 15:19 | 2/1/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -260 | 65.12 | 0 | -4 | -9 | 39 | D | | | | | | | | | | | | | | |
1/5/05 16:54 | 1/3/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 36 | 9.00 | 0 | 4 | 12 | 39 | D | | | | | | | | | | | | | | |
1/5/05 16:54 | 1/3/05 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -296 | 73.97 | 0 | -4 | -9 | 39 | D | | | | | | | | | | | | | | |
12/3/04 16:30 | 12/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 57 | 6.88 | 0 | 8 | 32 | 34 | D | | | | | | | | | | | | | | |
12/3/04 16:30 | 12/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -401 | 48.32 | 0 | -8 | -20 | 34 | D | | | | | | | | | | | | | | |
11/2/04 19:48 | 11/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 45 | 5.39 | 0 | 8 | 32 | 34 | D | | | | | | | | | | | | | | |
11/2/04 19:48 | 11/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -537 | 64.34 | 0 | -8 | -20 | 34 | D | | | | | | | | | | | | | | |
10/5/04 14:29 | 10/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 44 | 5.25 | 0 | 8 | 32 | 34 | D | | | | | | | | | | | | | | |
10/5/04 14:29 | 10/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -510 | 61.09 | 0 | -8 | -20 | 34 | D | | | | | | | | | | | | | | |
9/2/04 16:59 | 9/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 35 | 5.25 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
9/2/04 16:59 | 9/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -393 | 59.15 | 0 | -7 | -16 | 34 | D | | | | | | | | | | | | | | |
8/4/04 16:40 | 8/2/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 35 | 5.25 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
8/4/04 16:40 | 8/2/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -388 | 58.17 | 0 | -7 | -16 | 34 | D | | | | | | | | | | | | | | |
7/2/04 16:07 | 7/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 35 | 5.25 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
7/2/04 16:07 | 7/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -466 | 69.88 | 0 | -7 | -16 | 34 | D | | | | | | | | | | | | | | |
6/3/04 17:33 | 6/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 32 | 4.85 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
6/3/04 17:33 | 6/1/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -540 | 81.27 | 0 | -7 | -16 | 34 | D | | | | | | | | | | | | | | |
5/5/04 17:18 | 5/3/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 28 | 4.25 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
5/5/04 17:18 | 5/3/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -490 | 73.38 | 0 | -7 | -16 | 34 | D | | | | | | | | | | | | | | |
4/21/04 13:03 | 4/20/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M.d | 28 | 4.25 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
4/21/04 13:03 | 4/20/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S.d | -267 | 40.00 | 0 | -7 | -16 | 34 | D | | | | | | | | | | | | | | |
12/22/03 18:30 | 12/22/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M | 111 | 3.25 | 0 | 34 | 84 | 74 | D | | | | | | | | | | | | | | |
12/22/03 18:30 | 12/22/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S | -304 | 30.24 | 0 | -10 | -12 | 74 | D | | | | | | | | | | | | | | |
8/21/03 10:15 | 8/20/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | M | 22 | 3.98 | 0 | 6 | 116 | 10 | D | | | | | | | | | | | | | | |
8/21/03 10:15 | 8/20/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Colin | NY | DO | CEO | S | -193 | 35.00 | 0 | -6 | -35 | 10 | D | | | | | | | | | | | | | | |